Articles by Disease (Chronic Peptic Ulcer)

Molecular Therapeutic Targets in Inflammation: Cyclooxygenase and NF-κB

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 3
Page: 317-324
Author(s): Teresa Krakauer

Plant-Derived Leading Compounds for Eradication of Helicobacter pylori

Journal: Current Medicinal Chemistry - Anti-Infective Agents
Volume: 3
Page: 89-100
Author(s): Masami Kawase and Noboru Motohashi

Primary and Secondary Insomnia: Prevalence, Causes and Current Therapeutics

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 4
Page: 119-137
Author(s): Jaime M. Monti

Unique Profile of Lafutidine, A Novel Histamine H2-Receptor Antagonist - Mucosal Protection Throughout Gastrointestinal Tract Mediated by Capsaicin-Sensitive Afferent Neurons -

Journal: Drug Design Reviews - Online (Discontinued)
Volume: 1
Page: 133-144
Author(s): Sadayoshi Onodera, Kayoko Nishida and Koji Takeuchi

The Diversity of Epithelial Secreted Mucins

Journal: Current Organic Chemistry
Volume: 8
Page: 413-437
Author(s): Philippe Roussel and Philippe Delmotte

Clinical Pharmacology of Novel Selective COX-2 Inhibitors

Journal: Current Pharmaceutical Design
Volume: 10
Page: 589-601
Author(s): S. Tacconelli, M. L.. Capone and P. Patrignani

Cardiovascular and Renovascular Implications of COX-2 Inhibition

Journal: Current Pharmaceutical Design
Volume: 10
Page: 603-611
Author(s): Emma A. Meagher

Anti-Helicobacter pylori Agents. An Update

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 4
Page: 201-206
Author(s): E. M.F. Muri and J. S. Williamson

Th1-mediated Pathology in Mouse Models of Human Disease is Ameliorated by Concurrent Th2 Responses to Parasite Antigens

Journal: Current Topics in Medicinal Chemistry
Volume: 4
Page: 531-538
Author(s): Mark T. Whary and James G. Fox

Development of Immunopharmacotherapy Against Drugs of Abuse

Journal: Current Drug Discovery Technologies
Volume: 1
Page: 77-89
Author(s): Michael M. Meijler, Masayuki Matsushita, Peter Wirsching and Kim D. Janda